fig1
Figure 1. Medical management of diabetes in metabolic-bariatric surgery patients[52]. DPP4i: Dipeptidyl peptidase-4 inhibitor; GLP-1: glucagon-like peptide-1; RA: receptor agonist; SGLT2i: sodium-glucose transporter-2 inhibitor; VLCD: very low-calorie diet.
